Oryzon Genomics Eulerpool News

Oryzon Genomics Eulerpool News

Oryzon Genomics Notizie Azioni

Oryzon Genomics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Oryzon Genomics.

• 31 luglio ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8 luglio ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28 giugno ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26 giugno ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14 giugno ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3 giugno ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30 maggio ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29 maggio ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
• 9 maggio ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in May
• 6 maggio ·

  Yahoo
  ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024